SCHEMBL21246547

SCHEMBL21246547

COc1cc(N)cc(C(=O)NCc2cccnc2)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.70
ALDH1A1 P00352 3/20 0.63
L3MBTL1 Q9Y468 2/20 0.63
USP2 O75604 1/20 0.63
NPSR1 Q6W5P4 1/20 0.63
TSHR P16473 3/20 0.60
CYP1A2 P05177 2/20 0.60
CYP3A4 P08684 2/20 0.60
BLM P54132 1/20 0.60
CYP2C19 P33261 1/20 0.59
LMNA P02545 2/20 0.58
RECQL P46063 1/20 0.58
MAPK1 P28482 1/20 0.58
SMN1; SMN2 Q16637 2/20 0.57
MMP13 P45452 1/20 0.57
POLB P06746 1/20 0.57
HPGD P15428 1/20 0.57
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
KDM4E B2RXH2 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12330697 0.88 CA2 (0.62) GAAALDH1A1L3MBTL1USP2NPSR1
SCHEMBL21222741 0.84 GAA (0.61) GAAALDH1A1L3MBTL1USP2NPSR1
SCHEMBL29437183 0.84 GAA (0.61) GAAALDH1A1L3MBTL1USP2NPSR1
SCHEMBL8326064 0.83 GAA (1.00) GAAALDH1A1L3MBTL1USP2NPSR1
SCHEMBL21246615 0.82 NPC1 (0.60) GAAALDH1A1L3MBTL1USP2NPSR1
SCHEMBL21222739 0.82 NPSR1 (0.59) GAAALDH1A1L3MBTL1USP2NPSR1
SCHEMBL29437172 0.82 NPSR1 (0.59) GAAALDH1A1L3MBTL1USP2NPSR1
SCHEMBL29437184 0.80 NPC1 (0.61) GAAALDH1A1L3MBTL1USP2NPSR1
SCHEMBL5119797 0.80 NPC1 (0.61) GAAALDH1A1L3MBTL1USP2NPSR1
SCHEMBL5334343 0.80 MMP13 (0.79) GAAALDH1A1L3MBTL1USP2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12391647-B2 Benzamide compound and preparation method, use, and pharmaceutical composition thereof INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2025-08-19 US disclosed
US-20230099912-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2023-03-30 US disclosed
EP-3747866-B1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF INST MATERIA MEDICA CAMS (CN) 2023-03-01 EP disclosed
US-11518744-B2 Benzamide compound and preparation method, use, and pharmaceutical composition thereof INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2022-12-06 US disclosed
US-11518744-B2 Benzamide compound and preparation method, use, and pharmaceutical composition thereof INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2022-12-06 US disclosed
CN-110092743-B Benzamide compound, preparation method, application and pharmaceutical composition thereof 中国医学科学院药物研究所 2022-03-15 CN disclosed
US-20210047270-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2021-02-18 US disclosed
EP-3747866-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2020-12-09 EP disclosed
EP-3747866-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2020-12-09 EP disclosed
WO-2019149223-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF 中国医学科学院药物研究所 2019-08-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12391647-B2 Benzamide compound and preparation method, use, and pharmaceutical composition thereof JAK2, STAT3, STAT5A GAA 547/4885ALDH1A1 635/4885L3MBTL1 4608/4885
US-20230099912-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF JAK2, STAT3, STAT5A GAA 547/4885ALDH1A1 635/4885L3MBTL1 4608/4885
US-20210047270-A1 BENZAMIDE COMPOUND AND PREPARATION METHOD, USE, AND PHARMACEUTICAL COMPOSITION THEREOF JAK2, STAT3, STAT5A GAA 547/4885ALDH1A1 635/4885L3MBTL1 4608/4885
US-11518744-B2 Benzamide compound and preparation method, use, and pharmaceutical composition thereof JAK2, STAT3, STAT5A GAA 547/4885ALDH1A1 635/4885L3MBTL1 4608/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.